Huashan Shi

13PUBLICATIONS
35CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMedical molecular engineering of nucleic acids and proteinsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 06, 2025
Immunosenescence: signaling pathways, diseases and therapeutic targets.

Yichu Fu, Binhan Wang, Aqu Alu

|Mar 03, 2025
Ultra-high dose rate radiotherapy overcomes radioresistance in head and neck squamous cell carcinoma.

Hong-Shuai Li, Ruo Tang, Hua-Shan Shi

|Feb 25, 2025
A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariants.

Jingyun Yang, Weiqi Hong, Huashan Shi

|Jan 27, 2025
Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages.

Jingyun Yang, Xuemei He, Huashan Shi

|Aug 01, 2024
Revealing the crucial roles of suppressive immune microenvironment in cardiac myxoma progression.

Zedong Jiang, Qianlong Kang, Hong Qian

|Jun 06, 2024
Signaling pathways in colorectal cancer implications for the target therapies.

Yanlin Song, Ming Chen, Yuhao Wei

Pageof 3